Please use a PC Browser to access Register-Tadawul
Get It
AlphaTON Announces LOI Between ustralia's Asbestos and Dust Diseases Research Institute And Tarus Therapeutics To Conduct Investigator-Initiated Mesothelioma Clinical Trial of TT-4
AlphaTON Capital ATON | 1.36 | -3.19% |
